$ELV · Elevance Health, Inc.
Elevance Health, Inc. filed a Form 4 with the SEC on October 23, 2026, reporting changes in beneficial ownership by Mark Kaye, the company’s Executive Vice President and Chief Financial Officer. The filing discloses that on October 22, 2026, Kaye sold shares of Elevance Health common stock in a series of transactions.
The sales totaled 10,584 shares, executed in multiple trades at weighted average prices ranging from $434.00 to $447.19 per share. The individual transactions were reported in thirteen separate line items, each representing a group of trades within a narrow price range. Following these sales, Kaye directly owned 19,919 shares of Elevance Health common stock.
The filing does not report any acquisitions or transactions involving derivative securities. The reported sales were direct dispositions of common stock, and the filing includes standard undertakings to provide full trade details upon request to the SEC, the issuer, or a security holder.